Get the Stockscreener App
88.74
1.13%
0.99
Pre-market:
89.08
0.34
+0.38%
Globus Medical Inc stock is traded at $88.74, with a volume of 1.31M.
It is up +1.13% in the last 24 hours and up +43.92% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$87.75
Open:
$88
24h Volume:
1.31M
Relative Volume:
0.78
Market Cap:
$11.88B
Revenue:
$2.51B
Net Income/Loss:
$185.56M
P/E Ratio:
66.22
EPS:
1.34
Net Cash Flow:
$517.59M
1W Performance:
-2.57%
1M Performance:
+43.92%
6M Performance:
+48.74%
1Y Performance:
+5.13%
1-Day Range:
$87.20
$89.13
1-Week Range:
$87.20
$91.60
52-Week Range:
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
88.74 | 11.74B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-25 | Upgrade | Truist | Hold → Buy |
| Oct-28-25 | Resumed | Stifel | Hold |
| May-27-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
Is Globus Medical Inc. stock affected by interest rate hikes2025 Breakouts & Breakdowns & Low Risk High Win Rate Picks - Newser
Is Globus Medical Inc. Class stock considered safe havenMarket Activity Recap & Stepwise Entry and Exit Trade Signals - Newser
Insider Selling: Globus Medical (NYSE:GMED) CFO Sells 18,542 Shares of Stock - MarketBeat
Is It Too Late To Consider Globus Medical After Its Recent 43.9% Surge? - Yahoo Finance
Globus Says its Patent Win Over Life Spine Supported by Evidence - Bloomberg Law News
How forex fluctuations impact Globus Medical Inc. Class stockEarnings Growth Report & Consistent Profit Trading Strategies - Newser
What makes Globus Medical Inc. Class stock appealing to growth investors2025 AllTime Highs & Safe Entry Point Alerts - Newser
Can Globus Medical Inc. stock resist market sell offsRate Cut & Reliable Intraday Trade Alerts - Newser
Globus Medical Insider Sold Shares Worth $1,668,780, According to a Recent SEC Filing - marketscreener.com
Globus Medical (GMED) CFO Kline sells $1.66 million in stock By Investing.com - Investing.com Australia
Globus Medical (GMED) CFO Kline sells $1.66 million in stock - Investing.com
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" - sharewise.com
Globus Medical (GMED): Reassessing Valuation After Recent Share Price Momentum - sahmcapital.com
Sio Capital Management LLC Grows Stake in Globus Medical, Inc. $GMED - MarketBeat
Skandinaviska Enskilda Banken AB publ Acquires 23,300 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is Globus Medical Inc. (GM0N) stock worth holding before Fed meetingLayoff News & High Conviction Buy Zone Picks - Newser
How buyback programs support Globus Medical Inc. Class stockJuly 2025 Recap & Long-Term Safe Investment Ideas - Newser
Globus Medical, Inc. $GMED Shares Sold by Rhumbline Advisers - MarketBeat
Will Globus Medical Inc. Class stock outperform energy sector in 2025Weekly Trend Report & Daily Technical Stock Forecast Reports - moha.gov.vn
Globus Medical (NYSE:GMED) SVP Sells $675,000.00 in Stock - MarketBeat
Globus Medical SVP Huller sells shares for $675,000 By Investing.com - Investing.com South Africa
Globus Medical SVP Huller sells shares for $675,000 - Investing.com
How Should Investors View Globus Medical After Its 44% Surge and Mergers Buzz? - sahmcapital.com
How the Narrative Around Globus Medical Is Evolving After Recent Analyst and Market Updates - Yahoo Finance
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo Finance
Globus Medical Stock Jumps 44% In A Month, Time To Buy The Stock? - Trefis
Zacks.com featured highlights include Take-Two Interactive, Globus, Rockwell Automation, Canadian and VICI - Yahoo Finance
VP Huller Files To Sell 7,500 Of Globus Medical Inc [GMED] - TradingView
[144] GLOBUS MEDICAL INC SEC Filing - Stock Titan
Globus Medical (GMED): Assessing Valuation Following Strong Q3 Results and Upgraded Guidance - simplywall.st
Should You Buy Globus Medical (GMED) After Golden Cross? - sharewise.com
Globus Medical Stock Jumps 37% In A Month, Time To Buy The Stock? - Trefis
Globus Medical, Inc. (GM0N.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Globus Medical’s (GMED) Raised 2025 Guidance Changing the Investment Case for Investors? - sahmcapital.com
Globus Medical, Inc. (GM0N.F) stock price, news, quote and history - Yahoo Finance Australia
Merit Medical Systems, Globus Medical, Tenet Healthcare, Progyny, and IQVIA Shares Are Soaring, What You Need To Know - Finviz
Globus Medical Stock Jumps 32% In A Month, Time To Buy The Stock? - Trefis
Globus Medical, Inc. Class A Common Stock (NYSE:GMED) Stock Quote - Markets Financial Content
Will Globus Medical Inc. (GM0N) stock outperform Dow Jones2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
How Globus Medical Inc. (GM0N) stock correlates with oil marketsTrade Exit Report & Safe Capital Growth Plans - newser.com
A Look at Globus Medical (GMED) Valuation Following Its Recent 31% Share Price Rebound - Yahoo Finance
Will Globus Medical Inc. Class stock announce special dividendQuarterly Trade Report & Expert Approved Momentum Ideas - newser.com
Can Globus Medical Inc. (GM0N) stock double in coming yearsMarket Activity Recap & Real-Time Volume Analysis - newser.com
Can Globus Medical Inc. stock outperform in 2025 bull marketWeekly Stock Report & Smart Swing Trading Techniques - newser.com
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):